fbpx

R+D+I: Klinische Onderzoeken aan het Instituto Bernabeu

Efficacy of Urinary Vs Recombinant FSH in Oocyte Donors Based on Receptor N680S FSH Gene Polymorphism (Genodon Trial) (GENODON) NCT02625519

Efficacy of Urinary Vs Recombinant FSH in Oocyte Donors Based on Receptor N680S FSH Gene Polymorphism (Genodon Trial) (GENODON) NCT02625519

What is studied: It is the first clinical trial with a prospective and randomized design to assess the differences stimulation outcomes based on the gonadotropin used in patients with different genetic profiles.

Aim: We want to know the differences in the response to medication according to each woman’s genetic profile and the type of medication used.

Current status: Recruitment phase

Location: Instituto Bernabeu Alicante

For study details you can find them through the link

Laten we praten

Wij adviseren u vrijblijvend